Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder

NCT02046564 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ASC-01
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Co., Ltd.